340 related articles for article (PubMed ID: 9113001)
1. Intercellular adhesion molecule-1 in proliferative vitreoretinopathy.
Limb GA; Chignell AH; Cole CJ; Green WT; Webster L; Hollifield RD; Dumonde DC
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1043-8. PubMed ID: 9113001
[TBL] [Abstract][Full Text] [Related]
2. Soluble TNF receptors in vitreoretinal proliferative disease.
Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
[TBL] [Abstract][Full Text] [Related]
3. Elevated erythropoietin in vitreous of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
Wang ZY; Shen LJ; Zhao KK; Song ZM; Qu J
Ophthalmic Res; 2009; 42(3):138-40. PubMed ID: 19602911
[TBL] [Abstract][Full Text] [Related]
4. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy.
Limb GA; Hickman-Casey J; Hollifield RD; Chignell AH
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2453-7. PubMed ID: 10476819
[TBL] [Abstract][Full Text] [Related]
5. Vitreous levels of intercellular adhesion molecule 1 (ICAM-1) as a risk indicator of proliferative vitreoretinopathy.
Limb GA; Chignell AH
Br J Ophthalmol; 1999 Aug; 83(8):953-6. PubMed ID: 10413701
[TBL] [Abstract][Full Text] [Related]
6. Soluble apoptotic factors and adhesion molecules in rhegmatogenous retinal detachment.
Ricker LJ; Altara R; Goezinne F; Hendrikse F; Kijlstra A; La Heij EC
Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4256-62. PubMed ID: 21372012
[TBL] [Abstract][Full Text] [Related]
7. Vitreous intercellular adhesion molecule 1 in uveitis complicated by retinal detachment.
Webster L; Stanbury RM; Chignell AH; Limb GA
Br J Ophthalmol; 1998 Apr; 82(4):438-43. PubMed ID: 9640197
[TBL] [Abstract][Full Text] [Related]
8. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.
Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114
[TBL] [Abstract][Full Text] [Related]
9. Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Barile GR; Chang SS; Park LS; Reppucci VS; Schiff WM; Schmidt AM
Curr Eye Res; 1999 Sep; 19(3):219-27. PubMed ID: 10487959
[TBL] [Abstract][Full Text] [Related]
10. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
12. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema.
Funatsu H; Yamashita H; Sakata K; Noma H; Mimura T; Suzuki M; Eguchi S; Hori S
Ophthalmology; 2005 May; 112(5):806-16. PubMed ID: 15878060
[TBL] [Abstract][Full Text] [Related]
13. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study.
Kon CH; Occleston NL; Aylward GW; Khaw PT
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):705-12. PubMed ID: 10067974
[TBL] [Abstract][Full Text] [Related]
14. High TGF-beta2 levels during primary retinal detachment may protect against proliferative vitreoretinopathy.
Dieudonné SC; La Heij EC; Diederen R; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4113-8. PubMed ID: 15505063
[TBL] [Abstract][Full Text] [Related]
15. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
16. Comparison of interleukin-6 and matrix metalloproteinase expression in the subretinal fluid and the vitreous during proliferative vitreoretinopathy: correlations with extent, duration of RRD and PVR grade.
Symeonidis C; Papakonstantinou E; Androudi S; Georgalas I; Rotsos T; Karakiulakis G; Diza E; Dimitrakos SA
Cytokine; 2014 Jun; 67(2):71-6. PubMed ID: 24725542
[TBL] [Abstract][Full Text] [Related]
17. Chemokine levels in subretinal fluid obtained during scleral buckling surgery after rhegmatogenous retinal detachment.
Ricker LJ; Kijlstra A; de Jager W; Liem AT; Hendrikse F; La Heij EC
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4143-50. PubMed ID: 20335622
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
[TBL] [Abstract][Full Text] [Related]
19. Association between severity of vitreous haemorrhage and visual outcome in primary rhegmatogenous retinal detachment.
Yeung L; Yang KJ; Chen TL; Wang NK; Chen YP; Ku WC; Lai CC
Acta Ophthalmol; 2008 Mar; 86(2):165-9. PubMed ID: 17995984
[TBL] [Abstract][Full Text] [Related]
20. Elucidation of the pathogenic mechanism of rhegmatogenous retinal detachment with proliferative vitreoretinopathy by proteomic analysis.
Yu J; Peng R; Chen H; Cui C; Ba J
Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8146-53. PubMed ID: 23139279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]